Circulating Salicylic Acid and Metabolic Profile After 1-Year Nutritional⁻Behavioral Intervention in Children with Obesity
Overview
Authors
Affiliations
Methods: This was an interventional longitudinal observational uncontrolled cohort study. Forty-nine children with obesity, aged >6 years were evaluated. BMI (body mass index) z-scores were calculated. Fasting blood samples were analyzed for lipids, insulin, and glucose. The most significant metabolic variables were calculated. Serum SA was measured using a gas chromatography-mass spectrometry method. The 1-year intervention was based on the promotion of a balanced and normocaloric diet, in accordance with the national guidelines for treatment of childhood obesity. Additionally, behavioral education, based on the revised CALO-RE (Coventry, Aberdeen, and London-REfined) taxonomy, was performed.
Results: At the end of intervention, children showed an increase in serum SA levels (mean (Standard Deviation, SD) 0.06 (0.02) vs. 0.09 (0.05) µmol/L; < 0.001), a reduction of BMI z-score (3.14 (0.79) vs. 3.02 (0.82); < 0.001), TyG index (4.52 (0.20) vs. 4.48 (0.23); < 0.001), AIP (atherogenic index of plasma) (0.36 (0.21) vs. 0.27 (0.25); < 0.001), and triglycerides/HDL (high density lipoprotein) cholesterol (2.57 (1.28) vs. 2.18 (1.22); < 0.001) ratio. No statistically significant change in HOMA-IR (homeostasis model assessment index) was observed (4.20 (3.29) vs. 4.03 (2.28)). An association between the longitudinal variation of serum SA and HOMA-IR was found (correlation coefficient: -0.338, = 0.02).
Conclusion: Nutritional-behavioral intervention may improve the circulating SA and the metabolic profile in children with obesity. Serum SA could influence mainly glucose metabolism. Further larger studies are needed to evaluate whether a nutritional intervention based on specific advice regarding the quantity and type of fruit and vegetables (FV) consumption could provide benefits in terms of metabolic syndrome.
Xiang Q, Xu H, Zhan J, Lu S, Li S, Wang Y Nutrients. 2023; 15(18).
PMID: 37764852 PMC: 10535357. DOI: 10.3390/nu15184069.
A molecular signature for the metabolic syndrome by urine metabolomics.
Bruzzone C, Gil-Redondo R, Seco M, Barragan R, de la Cruz L, Cannet C Cardiovasc Diabetol. 2021; 20(1):155.
PMID: 34320987 PMC: 8320177. DOI: 10.1186/s12933-021-01349-9.